Samrat PharmaChem Ltd Samrat PharmaChem Ltd
Menu
  • Home
  • About
    • About Samrat
      • Company Overview
      • Company Culture
      • Management Team
      • Mission Vision & Philosophy
      • Registration Details
      • Production & Quality Policy
      +
    • Infrastructure Gallery
      • Plant & Machinery
      • Laboratory Equipments
      • Effluent Treatment Plant
      +
    • Careers
    +
    +
  • Products
    • Products (A-C)
      • 3-5 – Di Iodosalicylic Acid
      • Aluminium Iodide
      • Ammonium Iodide
      • Arsenic Iodide
      • Barium Iodide
      • Barium Mercuric Iodide
      • Cadmium Iodide
      • Calcium Iodate
      • Calcium Iodide
      • Clioquinol
      +
    • Products (C-I)
      • Copper Iodide
      • Cuprous Mercuric Iodide
      • Ethyl Iodide
      • Ethylenediamine Dihydroiodide
      • Hydriodic Acid 57%
      • Iodic Acid
      • Iodine
      • Iodine Monochloride
      • Iodophor
      • Iohexol
      +
    • Products (L-P)
      • Lithium Iodide
      • Magnesium Iodide
      • Mercuric Iodide
      • Methyl Iodide
      • Periodic Acid
      • Potassium Iodate
      • Potassium Iodide
      • Potassium Mercuric Iodide
      • Potassium Metaper Iodate
      • Potassium Tri Iodide Monohydrate
      +
    • Products (P-Z)
      • Povidone Iodine
      • Sodium Metaper Iodate
      • Sodium Iodate
      • Sodium Iodide
      • Tetra Butyl Ammonium Iodide
      • Tetra Ethyl Ammonium Iodide
      • Tetra Methyl Ammonium Iodide
      • Tri Methyl Sulphonium Iodide
      • Tri Methyl Sulphoxonium Iodide
      • Zinc Iodide
      +
    +
    +
  • Investors
    • Investor Services
    • Annual Reports
    • Quarterly Results
    • Share Holding Pattern
    • Message
    • Corporate Governance Report
    • Code of Conduct
    • Statutory Communications
    • Stock Price
    • Miscellaneous
    +
  • Policy
    • Corporate Social Policy
    • SHE Policy
    • Quality Policy
    • Privacy Policy
    • Insider Trading Policy
    • Preservation of Documents
    • Materiality of Events Policy
    • Whistleblower Policy
    • Related Party Transactions & its Materiality
    • Appointment of Independent Director
    +
  • Achievements
  • Contact
Posted on 29 Jan 2018
/ 0
/ webadmin

Notice of Board Meeting & Closure of Trading Window Q3 2017-18

Notice of Board Meeting & Closure of Trading Window Q3 2017-18

Give a Reply Cancel reply

Investors Relations

  • Annual Reports
  • Quarterly Results
  • Share Holding Pattern
  • Stock Price

Latest News

  • Notice Of Board Meeting & Closure of Trading Window – Q2 FY 2017-18 October 12, 2017
  • Notice of 25th AGM September 18, 2017
  • Notice of Board Meeting & Closure of Trading Window f.t.q.e. June 30, 2017 July 14, 2017

Contact Us

Corporate Office : 701/702, Business Square, M. A. Road, Andheri (West), Mumbai – 400 058, India

Phone : (91-22) 26701050/1/2

Fax : (91-22) 26701053

Email ID : samrat@bom4.vsnl.net.in

Website : www.samratpharmachem.com

Copyright © 2017 Samrat Pharmachem Limited | Powered By : Ginger Domain
  • Achievements
  • Company Overview
  • Contact